Inventor
SCAFETTA NAZARENO
IT14 patents
⚠️ This page may combine multiple inventors who share the name “SCAFETTA NAZARENO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SIGMA TAU IND FARMACEUTI
12 patentsUS6337349B2Jan 8, 2002
Solid compositions suitable for oral administration comprising an alkanoyl-l-carnitine magnesium citrate
SIGMA TAU IND FARMACEUTI28 citations92
US6051608AApr 18, 2000
Solid compositions suitable for oral administration comprising L-carnitine or alkanoyl-L-carnitine magnesium fumarate
SIGMA TAU IND FARMACEUTI14 citations73
US5543556AAug 6, 1996
Esters of acyl l-carnitines with gamma-hydroxybutyric acid and pharmaceutical compositions containing them for inhibiting neuronal degeneration and for the treatment of coma
SIGMA TAU IND FARMACEUTI7 citations73
US5534549AJul 9, 1996
Easters of acyl L-carnitines with gamma-hydroxybutyric acid and pharmaceutical compositions containing them for inhibiting neuronal degeneration and for the treatment of coma
SIGMA TAU IND FARMACEUTI6 citations73
US6180667B1Jan 30, 2001
Esters of acyl L-carnitines and pharmaceutical compositions containing same for treating endotoxic shock
SIGMA TAU IND FARMACEUTI5 citations72
US6130249AOct 10, 2000
Solid compositions suitable for oral administration comprising L-carnitine and alkanoyl-L-carnitine magnesium tartrate
SIGMA TAU IND FARMACEUTI3 citations62
US6124360ASep 26, 2000
Solid compositions suitable for oral administration comprising non hygroscopic salts of L-carnitine and alkanoyl-L-carnitine with 2-aminoethanesulfonic acid
SIGMA TAU IND FARMACEUTI3 citations62
US6080786AJun 27, 2000
Solid compositions suitable for oral administration comprising L-carnitine or alkanoyl-L-carnitine choline tartrate
SIGMA TAU IND FARMACEUTI2 citations62
US5625085AApr 29, 1997
Esters of acyl L-carnitines and pharmaceutical compositons containing same for treating endotoxic shock
SIGMA TAU IND FARMACEUTI4 citations61
US5532410AJul 2, 1996
Process for manufacturing L(-)-carnitine from a waste product having opposite configuration
SIGMA TAU IND FARMACEUTI4 citations59
US6465515B2Oct 15, 2002
Solid compositions suitable for oral administration containing non-hydroscopic salts of L-carnitine and alkanoyl L-carnitines
SIGMA TAU IND FARMACEUTI0 citations51
US6476243B1Nov 5, 2002
Perfluorinated esters of alkanoyl L-carnitine for the preparation of cationic lipids for the intracellular delivery of pharmacologically active compounds
SIGMA TAU IND FARMACEUTI0 citations42